Share profile
Up and Coming
Provided by Xin Tao
A former research scientist, Xin brings a deep understanding of the complex scientific issues that relate to the US legal compliance and government enforcement issues, enabling him to help clients with all phases of product development, manufacturing, and marketing. As the science and technology continues to evolve, Xin supports our clients to constantly innovate and push the boundaries of what's possible in the world of science.
Xin's practice focuses on advising high-growth companies and investors in food and beverage, healthcare, and e-commerce industries globally. As part of the Firm's US Government Enforcement Practice, he has represented many global companies during high-stakes US government investigations (including actions initiated by the US Congress, US Department of Justice (DOJ), and US Food and Drug Administration (FDA)) around the world. Xin also has a strong track record in US consumer product recall matters, and with a deep understanding of the intricacies involved in navigating the complex and interrelated legal and scientific issues, Xin can creatively and effectively represent companies in these bet-the-company cases.
As a seasoned US government regulatory and enforcement counsel, Xin works closely with global companies with novel pharmaceutical, medical device, food, and cosmetic applications that require the US government's pre-market approval or clearance and FDA Current Good Manufacturing Practices (cGMP) compliance.
• Co-author. "Key Legal Trends for Healthcare And Life Sciences In 2024," Law360, 8 January 2024
• Co-author. "Staying ahead of FDA drug cGMP enforcement," JD Supra, 03 February 2023
• Co-author. "Assuring the Food Safety of Crops Developed through Breeding," ACS Agricultural Science & Technology, 2022
• Co-author, "FDA completes first pre-market consultation for human food made with animal cell culture technology," JD Supra, 21 November 2022
• Co-author, "FDA Cites Five Companies for Illegally Selling Delta-8 THC and CBD Products," JD Supra, 18 May 2022
• Co-author, "What To Do As PFAS Food Packaging Phaseouts Approach," Law360, 21 January 2022
Provided by Chambers
Tao Xin is head of Baker McKenzie's US food and drug law practice. He has significant expertise across the full spectrum of FDA regulations.
Provided by Chambers
Xin has shown exceptional commercial awareness and commitment to client service.
Xin is very passionate about what he is working on, very experienced in the field and is always considerate of what the clients are thinking.
Xin Tao is an excellent FDA lawyer. He showed genuine empathy for our matter, which was much appreciated.
Xin has shown exceptional commercial awareness and commitment to client service.
Xin is very passionate about what he is working on, very experienced in the field and is always considerate of what the clients are thinking.
Xin Tao is an excellent FDA lawyer. He showed genuine empathy for our matter, which was much appreciated.